Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

NextGen Therapeutics

FDA's AI Model Enhances Safety of Biosimilar Therapeutic Proteins

Thanks to the FDA's new AI-powered imaging tool, the safety profile of newly developed biosimilar therapeutic protiens may improve.
Antibody & Protein Engineering

Interview with Andrew Brown, Head of Process Development Sciences at Lonza

Andrew Brown, Head of Process Development Sciences at Lonza, talks about Lonza's approach to process development.
Peptide Chemistry

AI-Discovered Peptide has Dramatic Impact on Muscle Conditioning

Are plant-derived peptides set to replace animal proteins as the go-to supplement for muscle conditioning?

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery